Idiopathic recurrent pericarditis as an autoinlammatory disease

Idiopathic recurrent pericarditis (IRP) is a rare disease, although up to 30% of patients with acute pericarditis can have recurrent pericarditis. IRP is currently regarded as an autoinflammatory condition driven by the disorder of the innate immune system. Polyserositis is a typical feature of the monogenic autoinlammatory diseases, e.g. familial Mediterranean fever. Moreover, variants in the genes responsible for these conditions are also observed in patients with IRP. The role of autoinflammation in the pathogenesis of IRP is also supported by the histological evidence and the efficacy of interleukin (IL)-1 inhibitors, which block the principal mediator of autoinlammation. The authors report the case of IRP that was effectively treated with goflicicept, the new IL-1 inhibitor. Clinical signs and symptoms, diagnosis and treatment of IRP are reviewed.

Authors

Publication Details

Journal
Clinical pharmacology and therapy
Published
2025-08-25
DOI
https://doi.org/10.32756/0869-5490-2025-3-65-73
Primary Topic
Pericarditis and Cardiac Tamponade
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Idiopathic recurrent pericarditis as an autoinlammatory disease

P. Novikov, Natalya Igorevna Troshina, A. Moiseev, A. Podusov et al.
Clinical pharmacology and therapy
Pericarditis and Cardiac Tamponade
article

Idiopathic recurrent pericarditis as an autoinlammatory disease

P. Novikov, Natalya Igorevna Troshina, A. Moiseev, A. Podusov, В. В. Рамеев, S. Moiseev
article en

Abstract

Idiopathic recurrent pericarditis (IRP) is a rare disease, although up to 30% of patients with acute pericarditis can have recurrent pericarditis. IRP is currently regarded as an autoinflammatory condition driven by the disorder of the innate immune system. Polyserositis is a typical feature of the monogenic autoinlammatory diseases, e.g. familial Mediterranean fever. Moreover, variants in the genes responsible for these conditions are also observed in patients with IRP. The role of autoinflammation in the pathogenesis of IRP is also supported by the histological evidence and the efficacy of interleukin (IL)-1 inhibitors, which block the principal mediator of autoinlammation. The authors report the case of IRP that was effectively treated with goflicicept, the new IL-1 inhibitor. Clinical signs and symptoms, diagnosis and treatment of IRP are reviewed.

Clinical pharmacology and therapyVol. 34(3)
Openalex Percentile: Top 58%
Pericarditis and Cardiac Tamponade
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.